Mark Cone - Nov 15, 2022 Form 4/A - Amendment Insider Report for biote Corp. (BTMD)

Role
Director
Signature
/s/ Marybeth Conlon, as Attorney-in-Fact for Mark Cone
Stock symbol
BTMD
Transactions as of
Nov 15, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
11/18/2022, 03:02 PM
Date Of Original Report
Nov 16, 2022
Previous filing
Dec 13, 2022
Next filing
Jan 4, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BTMD Stock Option (Right to Buy) Award $0 +31.7K $0.00 31.7K Nov 15, 2022 Class A Common Stock 31.7K $3.97 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All shares subject to the option award shall vest on the earlier of May 26, 2023 or the day prior to the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date.

Remarks:

This Amendment to the original Form 4 filed on November 16, 2022 (the "Original Form 4") is being filed solely to correct the exercise price in Column 2 of Table II. All other information in the Original Form 4 remains the same.